U.S. markets open in 7 hours 7 minutes
  • S&P Futures

    3,845.00
    +35.75 (+0.94%)
     
  • Dow Futures

    31,161.00
    +249.00 (+0.81%)
     
  • Nasdaq Futures

    13,092.50
    +181.50 (+1.41%)
     
  • Russell 2000 Futures

    2,238.00
    +38.80 (+1.76%)
     
  • Crude Oil

    62.65
    +1.15 (+1.87%)
     
  • Gold

    1,752.70
    +23.90 (+1.38%)
     
  • Silver

    27.08
    +0.64 (+2.40%)
     
  • EUR/USD

    1.2093
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3997
    +0.0075 (+0.54%)
     
  • USD/JPY

    106.5820
    +0.0800 (+0.08%)
     
  • BTC-USD

    46,184.64
    +1,747.35 (+3.93%)
     
  • CMC Crypto 200

    921.96
    -11.18 (-1.20%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

Raptor receives positive orphan drug opinion from EU committee

Raptor Pharmaceutical announced that it has received a positive opinion from the European Union Committee for Orphan Medicinal Products recommending orphan drug exclusivity for Procysbi gastro-resistant hard capsules for the treatment of proven nephropathic cystinosis. Final adoption of the opinions on drug approval and orphan exclusivity are expected from the European Commission in the coming months.